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ABSTRACT
Background: Cognitive insight is a relatively new concept. While cognition, clinical and cognitive insight are interrelated, the 
relationship is rather complex and the research so far is inconclusive.
Objectives: This study aimed to examine cognitive insight and its relationships with verbal learning, clinical insight, and 
severity of psychopathology among schizophrenia outpatient in Kelantan, Malaysia.
Methods: A total of 108 stable outpatient schizophrenia patients were recruited. Cognitive insight, psychopathology, verbal 
learning, and clinical insight were assessed using the Beck Cognitive Insight Scale (BCIS), Brief Psychiatric Rating Scale 
(BPRS), Auditory Verbal Learning Test (AVLT), and Insight and Treatment Attitudes Questionnaire (ITAQ), respectively.
Results: In multiple linear regression final model for BCIS-Composite, only female gender emerged as a significant associat-
ed factor. The final equation for BCIS-Composite was 2.746 + 1.99*(Gender) with 4% of the variation explained by gender (R2 = 
0.04). None of the other socio-demographic and clinical characteristics including psychopathology, clinical insight and verbal 
learning were significantly associated with the self-reflection, self-certainty and composite-index of cognitive insight 
Conclusions: Cognitive insight was not significantly associated with verbal learning, clinical insight, and severity of psycho-
pathology. The only significant factor was female gender which was positively correlated with composite-index of cognitive 
insight. 
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INTRODUCTION
Cognitive insight is conceptually different from clinical insight but 
occurring in a similar spectrum of insight1). Patients with schizophrenia 
who agreed that they could be wrong in their beliefs, showed better 
improvement in treatment outcome when psychological approach such 
as cognitive behavioural therapy (CBT) was given, as opposed to the 
other group of patients who were unshakable in their beliefs and 
received the same psychological approach2). This finding was later real-
ized to be linked to "cognitive insight", a term gaining ground only as 
recent as 2004. High self-certainty reflects greater certainty about being 
right and more resistant to correction (poor insight), while high self-re-
flection indicates the expression of introspection and the willingness to 
acknowledge fallibility (good insight)3).
Cognitive insight measures the ability of patient's higher mental 
functioning to assess and re-evaluate their distorted thoughts and 
beliefs, their openness to criticism, and how firmly they believe in their 
delusions3). In contrast to clinical insight, no significant change was 
observed in cognitive insight after treatment of acute psychosis suggest-
ing cognitive insight contributes to clinical insight but is not treat-
ment-dependent4). Schizophrenia patients with depression had signifi-
cantly higher score for self-reflection and self-certainty subscales as 
well as the mean composite index score5). Factors such as negative sym-
poms6) and depression7) may also play a role in determining good cogni-
tive insight.
A good clinical insight may also not necessarily be translated into 
good cognitive insight. Some patients may agree that they are mentally 
ill and the unusual experiences are due to mental disorder but without 
themselves being convinced of this3). It was found that self-reflection of 
cognitive insight, but not self-certainty, predicted severity of symptoms 
at 4-years after first episode psychosis (FEP)8). Cognitive insight, partic-
ularly the level of self-reflectiveness, is negatively associated with the 
level of subjective quality of life in outpatients with schizophrenia9). A 
reduction of positive symptoms was demonstrated as cognitive insight 
improved with CBT10,11). A more comprehensive assessment of patient 
mental state, therefore, requires evaluation of both cognitive and clinical 
insight. This is a good step to bring the patient to a more serious level of 
recovery by ensuring successful adherence to treatment and continuous 
engagement in a therapeutic doctor-patient partnership12).
In individuals with an FEP, cognitive insight may rely on memory 
whereby current experiences are appraised based on previous ones13). 
Excessively high self-certainty might be linked with weaknesses in cog-
nitive flexibility or set-shifting ability in people with at risk mental 
states (ARMS)14). Social cognitive abilities, particularly, theory of mind 
(ToM) is associated with clinical, but not cognitive insight, suggesting 
ToM impairment as contributing factors to poor insight in schizophre-
nia15,16). The close relationship between insight and cognition leads some 
authors to describe insight as being part of a neurocognitive model relat-
ed to frontal lobe function17,18). Recently, there has been a lot of interest 
in the study of neural correlates of cognitive insight. Higher self-certain-
ty was associated with thinner cortex in left posterior cingulate/precune-
us19) as well as hippocampal presubiculum atrophy, which is involved in 
episodic memory and cognitive control and is supposed to be under-
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pinned by difficulty in integrating new memories and thus in generating 
new hypotheses about the self20). Self-reflectiveness was positively cor-
related to activation in bilateral ventrolateral prefrontal cortex (VLPFC) 
in FES, but not in controls21). In addition, reduced posterior (occipi-
to-temporo-insulo-parietal) and increased anterior (orbitofrontal) cere-
bral metabolism may sustain low cognitive insight in psychosis22).
In order to improve insight, patients are given health education and 
counselling. Patient's cooperation, understanding as well as intact cogni-
tive ability to remember health-related advice are essential in order to 
produce a constant positive effect on one's mental health. This is depen-
dent on patient's ability to listen, comprehend and retain information, 
hence collectively called as "verbal learning" and it involves working 
memory process. Verbal learning, together with other cognitive abilities 
such as visual working memory and executive function, are part of neu-
rocognition. Nevertheless, linking both cognitive insight and neurocog-
nition is still not widely investigated and there have been no known 
published data yet to the author's knowledge regarding cognitive insight 
assessment in Malaysia. More knowledge about cognitive insight can be 
gained by exploring the relationship between the two domains in our 
Malaysian setting by using appropriate investigative tools. 
Therefore, this study aimed to examine cognitive insight and its 
relationships with verbal learning, clinical insight, and severity of psy-
chopathology among schizophrenia outpatient in Kelantan, Malaysia. 
Cognitive remediation therapies could later be formulated, suggested or 
devised to enhance neurocognitive abilities in order to improve cogni-
tive insight. Better cognitive insight inevitably helps elevate patient's 
potential functional outcome by achieving greater adherence to medica-
tion, therapies and simultaneously reducing relapses that have been 
linked to treatment non-compliance. 
Table 1. Socio-demographic, clinical and insight characteris-
tics of subjects (n = 108)
Variables  n (%)
Sex
   Male 63 (58.3)
   Female 45 (41.7) 
Race
   Malay 105 (97.2)
   Chinese 1 (0.9)
   Indian -
   Others 2 (1.9)
Marital Status
   Never married 74 (68.5)
   Married 21 (19.4)
   Divorced/separated 13 (12.0)
Employment Status
   Unemployed 59 (54.6)
   Employed  49 (45.4)
Educational Status
   Primary 4 (3.7)
   Secondary 73 (67.6)
   Tertiary  31 (28.7) 
Treatment Received
   Atypical antipsychotics 67 (62.0)
   Typical antipsychotics 24 (22.2)
   Both atypical and typical 17 (15.7) 
Benzhexol Use
   Yes  14 (13.0)
   No  94 (87.0)
 Mean(SD) Median(IQR)
Age (yrs.) 33.67(10.11)
Duration of Illness (yrs.) 10.96 (7.71)
BPRS   23 (5)*
Verbal Learning 
   Total learning 34.19 (10.61)
   Delayed recall  7.0 (4)*
   Recognition  14.0 (3)*
Insight data
   BCIS-SR 12.52 (4.62)
   BCIS-SC 8.93 (3.45)
   BCIS-Composite 3.57 (4.92)
   ITAQ 13.52 (4.16)
*Skewed distribution
Table 2. Correlation coefficients of BCIS with verbal learning, 
clinical insight and severity of psychopathology
Variables  BCIS-SR  BCIS-SC  BCIS-
     Composite
 r p- r p- r p-
  value  value  value
Total  0.13 0.19 0.09 0.36 0.06 0.56
learning
Delayed  0.06* 0.54 0.10* 0.30 -0.01* 0.93
recall
Recognition 0.06* 0.53 0.09* 0.39 0.03* 0.77
ITAQ 0.06 0.53 0.02 0.83 0.04 0.68
BPRS 0.05* 0.60 -0.12* 0.20 0.15* 0.13
r Pearson correlation coefficient, * Spearman correlation coefficient
Table 3. Associated factors of BCIS-SR by simple linear 
regression (n = 108)
Variables                                 BCIS-SR 
  ba (95%CI) tb stat p-value
Age  -0.00 (-0.09,0.09) -0.003 0.998
Gender  1.47 (-0.30,3.25) 1.648 0.102*
Race   
Malay   2.93 (-2.42,8.29) 1.086 0.280
Chinese -1.53 (-10.77,7.70)  -0.329 0.743
(Others)   
Marital Status   
Never married  -0.62 (-2.52,1.29) -0.643 0.522
Married  0.78 (-1.46,3.01) 0.689 0.493
(Divorced/Separated)   
Employment  -0.87 (-2.64,0.90) -0.980 0.329
Educational Status   
Primary  -2.88 (-7.53,1.78) -1.225 0.223*
Secondary  -0.33 (-2.22,1.56) -0.348 0.728
(Tertiary)   
Antipsychotics   
Atypical  -0.23 (-2.05,1.60) -0.245 0.807
Typical  -0.51 (-2.63,1.62) -0.472 0.638
(Both)   
Benzhexol Use  1.66 (-0.95,4.28) 1.260 0.210*
Duration of illness  0.02 (-0.10,0.13) 0.296 0.768
BPRS  0.05 (-0.22,0.32) 0.369 0.713
Verbal Learning   
Total learning  0.06 (-0.03,0.14) 1.316 0.191*
Delayed recall  0.20 (-0.12,0.51) 1.244 0.216*
Recognition  0.26 (-0.13,0.66) 1.315 0.191*
ITAQ  0.07 (-0.15,0.28) 0.627 0.532
a crude regression coefficient, bt statistic, *p < 0.25, included in the MLR 
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METHODS
Study setting and subjects
The ethical approval was granted by the Human Research Ethics 
Committee (USM/JEPeM/282.3(8) and Medical Research Ethics 
Committee (NMMR-13-1184-18386). This was a cross-sectional study 
conducted from March 2014 until November 2014. Patients age 18 to 65 
diagnosed with DSM-IV-TR schizophrenia attending outpatient psychi-
atric clinic at Hospital Universiti Sains Malaysia (USM) and Hospital 
Raja Perempuan Zainab II (HRPZ-II) for regular follow-up during the 
study period were invited to participate in the study. Those with cogni-
tive disorders, history of traumatic head injury, relapse of shizophrenia 
within the preceding 6 months, current or past alcohol or drug depen-
dence, major medical or neurological illness, mental retardation, and 
poor command of Malay language were excluded from the study.
The participant was explained about the reasons and aims of the 
study by the researcher. Informed consent was obtained. The subject 
was then asked to fill in the self-rated questionnaire of BCIS. After this 
was completed, the information on socio-demographic and clinical data 
was obtained from both interview and clinical records. These were 
entered into the socio-demographic and clinical data form by the 
researcher. Following this, the verbal learning test was then adminis-
tered using the Malay AVLT. Finally, the data collection was completed 
by using the BPRS to assess severity of psychopathology and the ITAQ 
to assess clinical insight during the interview.
Measurements 
a) The Beck Cognitive Insight Scale (BCIS) 
The BCIS is a 15-item self-rated scale, which includes two sub-
scales, self-reflection and self-certainty. Each item is rated on a Likert 
scale as "do not agree", "agree slightly", "agree a lot" and "agree com-
pletely" with each of these ratings given a score of 0,1,2 and 3 respec-
tively. Nine items assess self-reflection (items 1,3,4,5,6,8,12,14 and 15 
with a maximum score 27) while another six assess self-certainty (items 
2,7,9,10,11 and 13 with a maximum score 18). The self-reflection 
assesses openness to feedback, criticism and willingness to consider 
alternative explanations to unusual experiences. The self-certainty 
assess the extent of being overconfident with one's belief, where higher 
scores mean a lesser chance for delusion to be modified.3) High self-re-
flection and low self-certainty are considered normal23,24). To balance the 
two domains, a composite index is calculated to represent overall cogni-
tive insight. This is obtained by subtracting self-certainty scores from 
self-reflectiveness scores. A low composite score reflects poor cognitive 
insight. As of date, there is no common acceptable cut-off point to deter-
mine normal or abnormal scores of cognitive insight. This study utilized 
the validated Malay BCIS. Its Cronbach alpha value for overall, 
self-certainty and self-reflectiveness stood at 0.705, 0.609 and 0.699, 
respectively25). This was comparable to the original English version 
where the value stood at 0.61 for self-certainty and 0.67 for self-reflec-
tiveness in patients with schizophrenia3).
b) The Brief Psychiatric Rating Scale (BPRS) 
The BPRS is a clinician-rated tool published in 196226). It is used to 
assess severity of psychopathology covering symptoms of depression, 
anxiety and psychosis. This scale is well established and has been wide-
Table 4: Associated factors of BCIS- SC by simple linear 
regression (n = 108)
Variables                                                  BCIS- SC 
 ba (95%CI) tb stat p-value
Age 0.06 (-0.01,0.12) 1.695 0.093*
Gender -0.48 (-1.82,0.85) -0.717 0.475
Race   
Malay -0.08 (-4.09,3.94) -0.038 0.970
Chinese 1.08 (-5.79,7.96) 0.312 0.755
(Others)   
Marital Status   
Never married -0.06 (-2.04,0.79) -0.874 0.384
Married 0.45 (-1.22,2.11) 0.532 0.596
(Divorced/Separated)   
Employment 0.40(-0.92,1.72) 0.596 0.553
Educational Status   
Primary 1.38 (-2.11,4.86) 0.783 0.435
Secondary 0.06 (-1.35,1.47) 0.084 0.933
(Tertiary)   
Antipsychotics   
Atypical -0.91 (-2.25,0.44) -1.333 0.185*
Typical 0.79 (-0.79,2.37) 0.995 0.322
(Both)   
Benzhexol Use 1.72 (-0.21,3.65) 1.763 0.081*
Duration of illness 0.01 (-0.07,0.10) 0.337 0.737
BPRS -0.13 (-0.32,0.07) -1.250 0.214*
Verbal Learning   
Total learning 0.03 (-0.03,0.09) 0.928 0.355
Delayed recall 0.11 (-0.12,0.35) 0.960 0.339
Recognition 0.21 (-0.09,0.50) 1.376 0.172*
ITAQ 0.02 (-0.14,0.18) 0.210 0.834
a crude regression coefficient, bt statistic, *p < 0.25, included in the MLR
Table 5. Associated factors of BCIS-Composite by simple 
linear regression (n = 108)
Variables                                               BCIS- Composite 
 ba (95%CI) tb stat p-value
Age -0.06 (-0.15,0.04) -1.216 0.227*
Gender 1.98 (0.11,3.86) 2.102 0.038*
Race   
Malay 2.99 (-2.72,8.70) 1.038 0.301
Chinese -2.60 (-12.43,7.24) -0.524 0.602
(Others)   
Marital Status   
Never married 0.02 (-2.01,2.05) 0.022 0.983
Married 0.29 (-2.09,2.67) 0.243 0.808
(Divorced/Separated)   
Employment -1.31 (-3.19,0.57) -1.386 0.169*
Educational Status   
Primary -4.23 (-9.16,0.70) -1.702 0.092*
Secondary -0.33 (-2.35,1.68) -0.329 0.743
(Tertiary)   
Antipsychotics   
Atypical 0.69 (-1.25,2.63) 0.705 0.482
Typical -1.33 (-3.58,0.93) -1.168 0.246*
(Both)   
Benzhexol Use -0.08 (-2.89,2.73) -0.056 0.956
Duration of illness 0.00 (-0.12,0.13) 0.050 0.960
BPRS 0.18 (-0.11,0.46) 1.228 0.222*
Verbal Learning   
Total learning 0.03 (-0.06,0.12) 0.586 0.559
Delayed recall 0.09 (-0.25,0.43) 0.512 0.610
Recognition 0.06 (-0.36,0.49) 0.295 0.768
ITAQ 0.05 (-0.18,0.28) 0.413 0.680
a crude regression coefficient, bt statistic, *p < 0.25, included in the MLR
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ly used until now. According to Centre of Mental Health Services 
Research (CMHSR), BPRS is stated to have high inter-rater reliability 
(0.62 to 0.87) as well as both discriminant and concurrent validity in 
many studies27). Currently, the 18-item BPRS is the most widely used, 
which cover areas of somatic concern, anxiety, emotional withdrawal, 
conceptual disorganization, guilt feelings, tension, mannerisms and pos-
turing, grandiosity, depressive mood, hostility, suspiciousness, halluci-
natory behaviours, motor retardation, uncooperativeness, unusual 
thought content, blunted affect, excitement, and disorientation. Items are 
scored by the researcher during the interview with the patient and are 
based on a 7-point Likert scale with higher scores denoting greater 
severity. Total scores range from a minimum of 18 points to a maximum 
of 126 points.
c) The Auditory Verbal Learning Test (AVLT) 
The original Rey AVLT was validated into Malay language for local 
use in 2008. The Malay version of AVLT has a good factor validity (fac-
tor analysis of 0.66-0.98), test-retest reliability (0.24 to 0.84) and is sen-
sitive in discriminating between normal and schizophrenia subjects. The 
scale measures the patient's ability to encode, consolidate, store and 
retrieve verbal information as a test for verbal learning and memory. 
Each of List A and List B contains 15 nouns of Malay words obtained 
from five different categories (animals, tools, body parts, household 
items and vehicles)28). First, the participants in this study were required 
to listen to the items read out from List A and to repeat them. A total of 
five acquisition trials were given (A1, A2, A3, A4 and A5). The total 
acquisition trial is denoted as total learning (A1 + A2 + A3 + A4 + A5). 
Then, a new list (List B) was read out and participants were again 
required to remember the items in List B (B1, interference trial). The 
purpose of B1 is to interfere with the participant's memory storage abili-
ty. Immediately after B1, List A must be repeated (A6, post interference, 
immediate recall memory).A gap of 20 minutes was given after A6 
whereby at the end of this 20-minute gap, the participant was asked to 
recall List A again (A7, delayed memory recall). The final stage of the 
test involved recognising and identifying 15 List A words that were read 
out from a different list consisting of 30 words which were semantically 
or phonetically related. The researcher used a recorded audio as used in 
a previous study29) to standardize the auditory input to minimise errors 
of the auditory verbal learning data for the study. 
d) The Insight and Treatment Attitudes Questionnaire (ITAQ) 
The ITAQ was developed as a tool to measure clinical insight. Each 
of the 11 item on the scale is scored as 0 (no insight), 1 (partial insight) 
and 2 (good insight). Adding up the scores gives a total sum where high-
er values denote better insight. Scores range from a minimum of zero 
(worst) to a maximum of 22 (best). Different areas of insight, ranging 
from accepting the presence of mental disorder (first five items) to the 
patient's perspective towards medication, hospitalization and follow-up 
(last six items) are assessed. Studies have shown that the ITAQ had 
strong, significant correlation with both insight item of PANSS (r = 
0.9)30,31) and with open interview (r = 0.85) when assessing insight com-
monly done during mental state examination32). The ITAQ had been used 
in past studies in Malaysia to assess insight in schizophrenia33,34).
e) Socio-demographic and clinical data 
Socio-demographic and clinical data were obtained during the inter-
view to answer the objectives. In order to determine the associated fac-
tors relating to cognitive insight, verbal learning, clinical insight and 
severity of psychopathology in schizophrenia, variables such as patients' 
age, gender, race, marital status, employment status, educational level, 
duration of illness, types of antipsychotics received and the use of ben-
zhexol were included for analysis.
Statistical analysis
Descriptive statistics for socio-demographic, clinical data, severity 
of psychopathology, verbal learning and both cognitive and clinical 
insight scores were performed using Statistical Package for Social 
Sciences (SPSS) version 21. Mean (SD) was used for normally distrib-
uted continuous variables while median (IQR) was used to describe con-
tinuous variables of skewed distribution. Bivariate correlation analyses 
were performed for cognitive insight and verbal learning, clinical 
insight and severity of psychopathology to assess the correlation coeffi-
cients of the numerical variables. Simple and multiple linear regression 
(MLR) analysis methods were employed to identify associated factors 
of cognitive and clinical insight.
RESULTS
A total of 108 patients successfully completed the questionnaire and 
participated in the study. The self-rated questionnaires were checked by 
the researcher for any missing data before patients left the clinic. The 
mean age of patients included in this study was 33.7 years old. There 
were 63 males (58.3%) and 45 females (41.7%). The majority were 
Malays at 105 (97.2%). One Chinese and another two Malaysian of 
Siamese descent (others) patients made up the rest of the racial compo-
sition. Most of them were never married (n = 74; 68.5%) and unem-
ployed (n = 59; 54.6%). More than half of 108 patients received educa-
tion until secondary school level (n = 73; 67.6%). Almost a third (n = 
31; 28.7%) received education beyond that. For descriptive clinical data, 
62% of patients (n = 67) received atypical antipsychotics. This was then 
followed by typical antipsychotics at 22.2% while a small minority 
received both classes of medications (n = 17; 15.7%). The use of ben-
zhexol use was only seen in a fraction of patients (13%). A vast majority 
of schizophrenia patients were not prescribed benzhexol in their treat-
ment regime (n = 94; 87%). On average, patients showed a mean dura-
tion of illness of 10.96 years (SD = 7.71). 
The BPRS median score was 23 (IQR = 5). The verbal learning 
scores showed a mean total learning of 34.19 (SD = 4), median delayed 
recall of 7 and median recognition score of 14 (IQR = 3). The BCIS-SR, 
BCIS-SC, and composite means were 12.52 (SD = 4.62), 8.93 (SD = 
3.45) and 3.57 (SD = 4.92). Finally, mean ITAQ scores among 108 
patients were 13.52 (SD = 4.16). All measures of insight (BCIS-SR, 
BCIS-SC, BCIS-Composite and ITAQ) followed normal distribution. 
The results for correlation analyses for variables of interest are shown in 
table 2. From here, it can be seen that the cognitive insight in this pres-
ent study showed poor and non-significant relationships with scores of 
verbal learning, clinical insight and severity of psychopathology. 
Bivariate correlations were done for cognitive insight (BCIS-SR, 
BCIS-SC and BCIS-Composite) and numerical variables of verbal 
learning (total learning, delayed recall and recognition), clinical insight 
(ITAQ) and severity of psychopathology (BPRS) scores. To determine 
the associated factors of cognitive insight, two-step analyses were done 
to obtain the final model with significant factors. There was no signifi-
cant final model to describe associated factors for BCIS-SR and BCIS-
SC among patient with schizophreniain this study. In MLR final model 
for BCIS-Composite, only gender emerged as a significant associated 
factor. The final equation for BCIS-Composite was 2.746 + 
1.99*(Gender) with 4% of the variation explained by gender (R2 = 
0.04).
DISCUSSION
The present socio-demographic findings were consistent with an 
earlier study conducted in Kelantan, in which patients with schizophre-
nia had a mean age of 34 years, single (64.9%), unemployed (51.8%), 
educated until secondary school level (71.9%) and the majority of them 
were men (59.6%)35). Malays were the majority (97.2%) in this study 
which was consistent with ethnic composition in Kelantan where Malay 
made up 93.7%, followed by 3.3% Chinese, 0.2% Indian and 2.8% oth-
ers.
For clinical data, the BPRS scores were low (median 23) and this 
reflected patient's relatively stable mental health. Higher scores of 
BPRS indicate more profound psychopathology. One reason for this low 
score was that the study sample was chosen from outpatient clinics. 
Severely ill patients with loss of insight do not commonly visit outpa-
tient clinics and are also unable to be brought to the hospital by relatives 
due to their aggressive state. Those with severe psychopathology could 
also have been hospitalized for the relapse or were put under acute 
home care of community psychiatry services.
Assessment of verbal learning scores using Malay AVLT showed 
fairly consistent results as compared with an earlier study. The mean 
total learning score was 34.19 while the median score for delayed recall 
was 7. These results were not much different from a previous study con-
ducted among similar patient characteristics in Kelantan, which found 
the mean total learning scores to be 35.6. Mean for delayed recall score 
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was calculated to be 7.4 (SD = 2.71) while recognition was 12.6 (SD = 
2.60). All scores in the verbal learning parameters were globally lower 
than normal controls in that study35). In the present study, there were no 
significant associations between cognitive insight and all three verbal 
learning parameters. in keeping with the study by Garcia in 2012 who 
found that verbal learning was not associated with cognitive insight36). A 
meta-analysis found no significant associations between the self-reflec-
tiveness and neurocognition. By contrast there were small but signifi-
cant negative correlations between the self-certainty and memory (r = 
-0.23), IQ (r = -0.19) and total cognition (r = -0.14)37).
For cognitive insight, the mean measurement values in this study 
were 12.52 (SD = 4.62), 8.93 (SD = 3.45) and 3.57 (SD = 4.92) for 
BCIS-SR, BCIS-SC, BCIS-Composite, respectively. The scores are 
arbitrary where high self-reflection and low self-certainty are accepted 
as normal3,23,38). The BCIS scores in this study, nonetheless, revealed 
some parallel comparison to earlier studies done elsewhere. The original 
Beck and colleague's results based on a sample of 32 schizophrenia 
patients showed that the mean scores were 12.97 (SD = 5.00), 7.94 (SD 
= 3.78) and 5.03 (SD = 5.76) for BCIS-SR, BCIS-SC and BCIS-
Composite respectively3). Collectively, the range of mean values from 
other studies were: [BCIS-SR: mean 12.42-16.91; BCIS-SC: mean 8.2-
11.65; BCIS-Composite: mean 0.77-7.0]38-41). Hence, the local BCIS 
results did not differ markedly from other worldwide studies but it is 
still too early to draw any firm conclusion because of the different meth-
odologies, inclusion criteria and diagnostic classifications employed.
The study also showed that the correlation coefficients were poor 
between the two insight scales. The most acceptable reason for this find-
ing is that the two insight scales measure different constructs. There is a 
shortage of published literature in assessing the correlation coefficients 
between BCIS and ITAQ. However, BCIS has been shown to have a 
low correlation with other questionnaires measuring clinical insight 
while ITAQ, on the other hand, has good correlations with other scales 
of clinical insight42). The poor, non-significant correlations between 
BCIS and ITAQ in the present study thus affirmed the BCIS as a tool to 
measure cognitive insight, and not clinical insight.
The BCIS scores among all three domains (BCIS-SR, BCIS-SC and 
BCIS-Composite) in our study did not show any significant associations 
with socio-demographic factors except for gender in the final model for 
BCIS-Composite. The absence of other significant socio-demographic 
variables was in line with previous studies showing non-significant rela-
tionship with the socio-demographic factors3,39,43,44). While age and edu-
cational status affect cognitive functions, these factors appeared to have 
no significant effect on cognitive insight, despite the theory of cognitive 
insight being a part of the neurocognitive model. Nevertheless, it is still 
a matter of interest to note that the female gender in this study was 
found to show higher composite scores of BCIS over males. On the 
basis of theoretical and cultural aspect, we thus suggested a few reasons 
for this positive association found in our present study.
Firstly, the relationship between cognitive insight and neurocogni-
tion in patients with schizophrenia is sexually dimorphic. Sex moderates 
the association between executive function and cognitive insight in 
schizophrenia. Poor executive function was significantly correlated with 
impaired cognitive insight for males with schizophrenia, but not for 
females46). It is well known that females have later age of onset and bet-
ter overall prognosis of schizophrenia than males. Consequently, 
females at comparative age may have better cognitive function, thereby 
allowing them better cognitive flexibility to reflect upon their thoughts 
and ultimately showing better composite scores of cognitive insight than 
their opposite gender. 
Secondly, gender bias may play a part in this finding. The male gen-
der has been given a societal role and expectation on how a man is sup-
posed to think, act and feel. This assumed gender role has made males 
to be less likely to show their emotions and to think more decisively. 
This could then be translated to males being more confident in their 
thinking and that could have affected the composite scores of BCIS by 
producing greater self-confidence (BCIS-SC) and less flexibility or 
reflectiveness (measured by BCIS-SR), ultimately leading to lower 
BCIS-Composite scores than females. Additionally, better cognitive 
insight has been shown to be associated with depressive symptoms in 
schizophrenia where composite index and self-reflection of BCIS is 
positively correlated with depression scores7).
The third reason is related to the effects of antipsychotic medica-
tions on the cognitive ability to reappraise thoughts or beliefs. Although 
our study did not investigate the dose of antipsychotics used or attempt 
to control this factor, it has to be recognized that high dose of antipsy-
chotics tend to show greater side effects, including cognitive blunting 
and sedation. Since females with schizophrenia tend to exhibit better 
prognosis and functional outcome, they could be associated with the use 
of lower doses of antipsychotics as compared to males. As a result, less-
er side effects occur and this would give rise to better cognitive function 
to self-evaluate their own thoughts in BCIS. 
Therefore, as this was a pioneering study on cognitive insight in 
Kelantan, the absence of significant variables other than gender to pre-
dict the BCIS scores does not exclude the presence of other hidden 
covariates that could influence the effect of gender on composite scores. 
The current finding could also be too early to be concluded upon, as the 
predictability power was weak. The R2 value for this association was 
0.04. In other words, it means that only 4% of the variance in the final 
model of BCIS-Composite is explained by gender difference. More 
studies need to be conducted to explore other variables that could be 
associated with cognitive insight.
CONCLUSIONS
Cognitive insight was not significantly associated with verbal learn-
ing, clinical insight, and severity of psychopathology. The only signifi-
cant factor was female sex which was positively correlated with com-
posite-index of cognitive insight. 
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